Catalyst Biosciences Inc (CBIO) Stock Falls -9.09% This Week; Should You Buy?
Wednesday, March 22, 2023 03:16 PM | InvestorsObserver Analysts
Mentioned in this article
Catalyst Biosciences Inc (CBIO) stock is down -71.83% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CBIO stock a score of 22 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 8. CBIO's rank also includes a short-term technical score of 57.
CBIO has an Overall Score of 22. Find out what this means to you and get the rest of the rankings on CBIO!
Catalyst Biosciences Inc (CBIO) stock is up 5.14% while the S&P 500 is down -0.11% as of 3:01 PM on Wednesday, Mar 22. CBIO is up $0.01 from the previous closing price of $0.19 on volume of 144,136 shares. Over the past year the S&P 500 is lower by -11.38% while CBIO is down -71.83%. CBIO earned $0.38 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.54.
Click Here to get the full Stock Report for Catalyst Biosciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter